UTSI [UTSTARCOMS] 6-K: (Original Filing)

[UTStarcom Reports Unaudited Financial Results for the Third quarter of 2013 BEIJING, China, November 14, 2013 — UTStarcom Holdings Corp. (“UTStarcom” or “the Company”) (NASDAQ: UTSI), a leading provider of media operational support services and broadband products and services, today reported its unaudited financial results for the quarter ended September 30, 2013. As previously announced, the Company closed the divestiture] [UTStarcom Holdings Corp. Third Quarter 2013 Results NASDAQ: UTSI November 2013 Mr. William Wong, CEO Mr. Robert Pu, CFO 1 3 Earnings Call Agenda Update on Operating Progress Overview of Third Quarter 2013 Results 1 Withdrawal of Non-Binding Going Private Proposal 2 3 Company Outlook 4 Summary of Key Highlights 5 Update on Operating Progress 4 A Summary of Operating]

By | 2016-03-01T10:35:52+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments
Read More

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014 2Q14 New Subscribers Reached 15,928 2Q14 Revenue Up 10.3% YOY to RMB141.6 Million 2Q14 Operating Income Up 19.7% YOY to RMB56.3 Million Conference Call to be Held November 15, 2013 at 8:00 a.m. ET HONG KONG, China, November 14, 2013 -- China Cord]

By | 2016-02-29T12:55:13+00:00 November 14th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By | 2016-03-01T03:53:33+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

NTES [NetEase] 6-K: (Original Filing)

[Contact for Media and Investors: Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Third Quarter 2013 Unaudited Financial Results (Beijing November13, 2013) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the third quarter ended]

By | 2016-01-11T11:13:06+00:00 November 14th, 2013|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments
Read More

MY [CHINA MING YANG WIND POWER] 6-K: (Original Filing)

[China Ming Yang Wind Power Group Limited Company (the “ Notice of Annual General Meeting of the Company AGM Notice is hereby given that an Annual General Meeting of the Company (the “ 1 As an ordinary resolution that the Company’s audited consolidated financial statements for the fiscal year ended December 31, 2012 be approved and adopted; 2 As an] [China Ming Yang Wind Power Group Limited Company (the “ FORM OF PROXY FOR SHAREHOLDERS I/We Please Print Name(s) of Please Print Address(es) being (a) shareholder(s) of the Company with shares respectively hereby appoint of or failing him/her of Chairman AGM or failing him/her the duly appointed chairman of the AGM (the “ Resolution For Against Abstain 1. As an]

By | 2016-02-29T22:21:12+00:00 November 14th, 2013|Categories: Chinese Stocks, MY, SEC Original|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093013.htm]

By | 2016-03-03T16:35:28+00:00 November 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Read More

NFEC [NF Energyvingrp] 10-Q: (Original Filing)

[FORM 10-Q x September 30 , 2013 NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Room 3106 Block C, 390 Qingnian Avenue, Heping District Shenyang, P. R. China 110002 (8624) 2560-9775 x o x o o o Large accelerated filer o] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Lihua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Gang Li ( v360177_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Lihua, Wang Principal Financial and Accounting Officer) ( v360177_ex32-2.htm]

By | 2016-02-08T06:51:22+00:00 November 14th, 2013|Categories: Chinese Stocks, NFEC, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-03-03T10:36:46+00:00 November 14th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

YY [YY] 6-K: (Original Filing)

[QuickLinks -- Click here to rapidly navigate through this document YY INC. GUANGZHOU, CHINA—November 14, 2013: YY Inc. (NASDAQ: YY), a revolutionary rich communication social platform ("YY" or the "Company"), today announced that it proposes to offer up to US$250 million in aggregate principal amount of convertible senior notes due 2018 (the "notes"), subject to market conditions and other factors.] [QuickLinks -- Click here to rapidly navigate through this document YY Inc. Page Interim Condensed Consolidated Financial Statements (unaudited) Unaudited Interim Condensed Consolidated Balance Sheets as of December 31, 2012 and September 30, 2013 2 Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Income for the Nine Months Ended September 30, 2012 and 2013 4 Unaudited Interim Condensed Consolidated] [QuickLinks -- Click here to rapidly navigate through this document Discussion of Selected Statements of Operations Items Revenues In the nine months ended September 30, 2013, we primarily derived our revenues from internet value-added services, or IVAS, and online advertising. Our IVAS revenues are primarily comprised of revenues from the paying users of YY Music, online games and, to a]

By | 2016-03-01T20:24:05+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, YY|Tags: , , , , , |0 Comments
Read More
Skip to toolbar